Uplinza

Amgen's muscular disorder drug meets main goal in late-stage study
Reuters
Tue, 09/24/24 - 09:59 pm
Amgen
Uplinza
clinical trials
myasthenia gravis
Amgen's drug meets main goal in late-stage study for rare disease
Reuters
Wed, 06/5/24 - 11:03 am
Amgen
clinical trials
Uplinza
IgG4-RD
AstraZeneca spinoff scores maiden FDA approval, where it will field Alexion competition and an imminent Roche rival
Endpoints
Fri, 06/12/20 - 10:40 am
Viela Bio
AstraZeneca
Uplinza
FDA
NMOSD